SFX by Ex Libris Inc.

Title:	Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation
Source:	Nucleic Acids Research [0305-1048] Costello, M yr:2013

Basic

Full text

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Vogel, U. "Ion Torrent Personal Genome Machine Sequencing for Genomic Typing of Neisseria meningitidis for Rapid Determination of Multiple Layers of Typing Information." Journal of clinical microbiology 50.6 (2012): 1889-1894.
description	2.	De Santis, D. "HLA GENOTYPING ON THE PERSONAL GENOME MACHINE (ION TORRENT) MAY BE THE NEXT GENERATION IN THE HLA LABORATORY." Tissue antigens 2012. 428-429.
description	3.	Natsoulis, G. "Performance comparison of whole-genome sequencing platforms." Nature biotechnology 30.1 (2011): 78-82.
description	4.	Jacob, Howard J. "Next-Generation Sequencing for Clinical Diagnostics." The New England journal of medicine 369.16 (2013): 1557-8.
description	5.	Lundeberg, J. "Rapid flow-sorting to simultaneously resolve multiplex massively parallel sequencing products." Scientific Reports 1 (2011).
description	6.	Carlone, Lionel K K K. "Advances in the development of vaccines against Neisseria meningitidis." New England Journal of Medicine, The 362.16 (2010): 1511-1520.
description	7.	Yang, Y. "Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders." The New England journal of medicine 369.16 (2013): 4294967295-1511.
description	8.	JÃ¼nemann, S. "Updating benchtop sequencing performance comparison." Nature biotechnology 31.4 (2013): 294-296.
description	9.	Liu, L. "Comparison of next-generation sequencing systems." Journal of Biomedicine and Biotechnology 2012 (2012): 1-251364.
description	10.	Quail, M. "A tale of three next generation sequencing platforms: comparison of Ion torrent, pacific biosciences and illumina MiSeq sequencers." BMC genomics 13.1 (2012): 341-341.
description	11.	Vucic, Emily A. "Translating cancer 'omics' to improved outcomes." Genome research 22.2 (2012): 188-195.
description	12.	Lyon, E. "Next Generation Sequencing in Clinical Diagnostics: Experiences of Early Adopters." Clinical Chemistry 61.1 (2014): 41-9.
description	13.	Howden, Benjamin P. "Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR." PLOS pathogens 7.11 (2011).
description	14.	Margulies, M. "Genome sequencing in microfabricated high-density picolitre reactors." Nature 437.7057 (2005): 376-380.
description	15.	Mestan, K. "Genomic Sequencing in Clinical Trials." Journal of translational medicine 9.1 (2011): 222-222.
description	16.	Momiao, X. "Next-Generation Sequencing." Journal of Biomedicine and Biotechnology 2010.5 (2011): 1-2.
description	17.	Glenn, Travis C. "Field guide to next-generation DNA sequencers." Molecular ecology resources 11.5 (2011): 759-769.
description	18.	Billard-Pomares, T. "Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5 to 18 years old cystic fibrosis patients." Journal of medical microbiology 60.2 (2010): 157-161.
description	19.	[Anon]. "LIFE TECHNOLOGIES TO BUY ION TORRENT." Chemical & engineering news 88.34 (2010): 18-18.
description	20.	Moghimi, S.M. M. "Liposome-mediated triggering of complement cascade." Journal of liposome research 18.3 (2008): 195-209.